home / stock / rnxt / rnxt news

RNXT News and Press, RenovoRx Inc. From 01/08/26

Stock Information
Company Name: RenovoRx Inc.
Stock Symbol: RNXT
Market: NASDAQ
Website: renovorx.com
Menu
RNXT RNXT Quote RNXT Short RNXT News RNXT Articles RNXT Message Board
Get RNXT Alerts

News, Short Squeeze, Breakout and More Instantly...
RNXT - The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – Biopharma M&A is entering a fever pitch, with precision oncology investments alone exploding to $138 billion as major players scramb...
RNXT - RenovoRx To Announce Promising New Clinical Data Using its TAMP(TM) Therapy Platform in an Abstract to be Presented at ASCO GI 2026

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx’s TAMP Therapy Platform as a Targeted Drug-Delivery Approach Data Shows a PK Profile that May Improve Clinical Efficacy and Decrease Clinical Side Effects with ...

RNXT - Catalyst Watch: AI spotlight at CES, Versant starts trading, and the December jobs report

2026-01-02 15:00:31 ET More on the markets Realistic Expectations For 2026 Market Rotation Alert: Positioning For A Potentially Tumultuous Year S&P 500 And Bitcoin: After 4 Years Of Mediocrity From The Latter, I Own Both, Here's Why Steady start to 2026: ...

RNXT - RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026

MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a patented,...
RNXT - RenovoRx, Inc. (RNXT) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

2025-12-09 14:57:05 ET RenovoRx, Inc. (RNXT) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 12:30 PM EST... Read the full article on Seeking Alpha For further details see: RenovoRx, Inc. (RNXT) Presents at IAccess Alpha Virtual Best Ideas...

RNXT - Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025

RALEIGH, NC / ACCESS Newswire / December 8, 2025 / iAccess Alpha's Virtual Best Ideas Winter Investment Conference will take place on December 9-10, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities. ...

RNXT - RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th

MOUNTAIN VIEW, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a novel, FDA-...
RNXT - RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th

MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a novel, FDA-cleared ...

RNXT - RenovoRx GAAP EPS of -$0.08 in-line, revenue of $0.2M misses by $0.1M

2025-11-13 16:19:55 ET More on RenovoRx Seeking Alpha’s Quant Rating on RenovoRx Historical earnings data for RenovoRx Financial information for RenovoRx Read the full article on Seeking Alpha For further details see: RenovoRx GAAP EPS of -...

RNXT - RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

September 30, 2025 Cash and Cash Equivalents at $10 million Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn Management to Host Conference Call Today at 4:30 p.m. ET MOUNTAIN VIEW, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (...
Previous 10 Next 10